Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21732502 | 0.94 | ALDH1A1 (0.32) | CYP1A2USP2LMNACYP3A4CYP2D6 | |
| SCHEMBL21732482 | 0.94 | MEN1 (0.32) | CYP1A2USP2LMNACYP3A4CYP2D6 | |
| SCHEMBL21732493 | 0.87 | — | — | |
| SCHEMBL21732406 | 0.87 | ALDH1A1 (0.32) | CYP1A2USP2LMNACYP3A4CYP2D6 | |
| SCHEMBL21732504 | 0.87 | — | — | |
| SCHEMBL21732550 | 0.86 | MEN1 (0.37) | CYP1A2USP2LMNACYP3A4CYP2D6 | |
| SCHEMBL21732498 | 0.85 | MEN1 (0.36) | CYP1A2USP2LMNACYP3A4CYP2D6 | |
| SCHEMBL19298416 | 0.84 | ALDH1A1 (0.32) | — | |
| SCHEMBL25004588 | 0.84 | ALDH1A1 (0.32) | — | |
| SCHEMBL22986981 | 0.84 | MAPT (0.38) | CYP1A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210053934-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| WO-2020036314-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DIODE USING SAME | 주식회사 엘지화학 | 2020-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210053934-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | AOX1, CRY1, ALDH1A2 | CYP1A2 25/4885USP2 2960/4885LMNA 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.